Redi.Health, a Columbus, OH-based provider of a health management technology platform, secured a growth funding of undisclosed amount.
The round was led by Refinery Ventures, with participation from MCP, Rev1 Ventures, and M25.
The company intends to use the funds to expand its business reach.
Led by CEO Luke Buchanan, Redi.Health empowers patients with chronic conditions to understand, manage and track their total health through digital support. Combining health management technology and pharmaceutical manufacturer support into one tool, the company also provides a mobile platform that allows patients to manage everything from multiple medications and symptoms to diet and exercise.
Redi.Health recently signed partnerships with several healthcare heavyweights like GoodRx and ScriptDrop, as well as a collaboration with Labcorp that integrates the Labcorp Drug Development Patient Access Solutions with its digital support platform to connect patients and providers. The company expects to continue to accelerate in 2023 with more advancements for improved patient outcomes.
FinSMEs
18/10/2022